COMBINED ANTI TUMOR THERAPY WITH A GITR AGONIST AND CPG

• 收藏
• 分享

专利权人:

Five Prime Therapeutics; Inc.

发明人:

Susan Foy,Thomas Brennan,Danielle Kellar

申请号：

US16310725

公开号：

US20190263919A1

申请日:

2017.06.30

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present disclosure relates to methods of using glucocorticoid-induced TNFR-related protein (GITR) agonists as anti-tumor agents, for example in combination with CpG oligodeoxynucleotides. A specific antibody, characterized by its CDRs is described as agonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/